Immunovant Unveils Durability and Treatment-Free Six-month Remission Data with Potential to Change Treatment Paradigm for Uncontrolled Graves’ Disease Patients

globenewswire

Immunovant Unveils Durability and Treatment-Free Six-month Remission Data with Potential to Change Treatment Paradigm for Uncontrolled Graves’ Disease Patients – NEWSnet – News… as it used to be

More Press Releases

April 28, 2026

FISV ALERT: Shareholder Rights Law Firm Julie & Holleman LLP Is Investigating Fiserv’s Directors and Officers for Potential Wrongdoing

April 28, 2026

MAX SPECIAL ALERT: Julie & Holleman LLP Is Investigating Potential Misconduct at MediaAlpha

April 28, 2026

Spring Economic Update already cashed-in, leaving little room for growth agenda

April 28, 2026

Immunovant Unveils Durability and Treatment-Free Six-month Remission Data with Potential to Change Treatment Paradigm for Uncontrolled Graves’ Disease Patients

FISV ALERT: Shareholder Rights Law Firm Julie & Holleman LLP Is Investigating Fiserv’s Directors and Officers for Potential Wrongdoing

MAX SPECIAL ALERT: Julie & Holleman LLP Is Investigating Potential Misconduct at MediaAlpha

Spring Economic Update already cashed-in, leaving little room for growth agenda

OTIC Investors Have Opportunity to Join Blue Owl Technology Income Corp. Fraud Investigation with the Schall Law Firm